These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 1428060

  • 1. DNA analysis of breast cancer by flow cytometry & correlation with other prognostic parameters.
    Redkar AA, Balsara BR, Bhisey AN, Sampat MB, Mittra I.
    Indian J Med Res; 1992 Aug; 96():223-9. PubMed ID: 1428060
    [Abstract] [Full Text] [Related]

  • 2. Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters.
    Rosanelli GP, Steindorfer P, Wirnsberger GH, Klimpfinger M, Ratschek M, Puerstner P, Auner H, Berhold A.
    Anticancer Res; 1995 Aug; 15(2):581-6. PubMed ID: 7763041
    [Abstract] [Full Text] [Related]

  • 3. Flow cytometric DNA analysis as prognostic factor in human breast carcinoma.
    Ottestad L, Pettersen EO, Nesland JM, Hannisdal E, Fosså SD, Tveit KM.
    Pathol Res Pract; 1993 May; 189(4):405-10. PubMed ID: 8351241
    [Abstract] [Full Text] [Related]

  • 4. S-phase fraction determined on fine needle aspirates is an independent prognostic factor in breast cancer - a multivariate study of 770 patients.
    Gazic B, Pizem J, Bracko M, Cufer T, Borstnar S, Pohar-Marinsek Z, Us-Krasovec M.
    Cytopathology; 2008 Oct; 19(5):294-302. PubMed ID: 18070112
    [Abstract] [Full Text] [Related]

  • 5. Prognostic significance of DNA image cytometry in Libyan breast cancer.
    Ermiah E, Abdalla F, Buhmeida A, Alshrad M, Salem N, Pyrhönen S, Collan Y.
    Oncology; 2012 Oct; 83(3):165-76. PubMed ID: 22906963
    [Abstract] [Full Text] [Related]

  • 6. [Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer].
    Moureau-Zabotto L, Bouchet C, Cesari D, Uzan S, Lefranc JP, Antoine M, Genestie C, Deniaud-Alexandre E, Bernaudin JF, Touboul E, Fleury-Feith J.
    Cancer Radiother; 2005 Dec; 9(8):575-86. PubMed ID: 16243560
    [Abstract] [Full Text] [Related]

  • 7. Relationship between DNA ploidy and survival in patients with primary breast cancer.
    Eskelinen MJ, Pajarinen P, Collan Y, Pesonen E, Alhava E, Kettunen K, Nordling S.
    Br J Surg; 1989 Aug; 76(8):830-4. PubMed ID: 2765840
    [Abstract] [Full Text] [Related]

  • 8. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer.
    Moureau-Zabotto L, Bouchet C, Cesari D, Uzan S, Lefranc JP, Antoine M, Genestie C, Deniaud-Alexandre E, Bernaudin JF, Touboul E, Fleury-Feith J.
    Breast Cancer Res Treat; 2005 May; 91(1):61-71. PubMed ID: 15868432
    [Abstract] [Full Text] [Related]

  • 9. DNA analysis and S-phase fraction determination by flow cytometric analysis of infiltrating lobular carcinoma of the breast.
    Frost AR, Karcher DS, Terahata S, Siegel RS, Silverberg SG.
    Mod Pathol; 1996 Sep; 9(9):930-7. PubMed ID: 8878026
    [Abstract] [Full Text] [Related]

  • 10. S-phase fraction and DNA ploidy in 633 T1T2 breast cancers: a standardized flow cytometric study.
    Chassevent A, Jourdan ML, Romain S, Descotes F, Colonna M, Martin PM, Bolla M, Spyratos F.
    Clin Cancer Res; 2001 Apr; 7(4):909-17. PubMed ID: 11309341
    [Abstract] [Full Text] [Related]

  • 11. Prognostic significance of morphological parameters and flow cytometric DNA analysis in carcinoma of the breast.
    Visscher DW, Zarbo RJ, Greenawald KA, Crissman JD.
    Pathol Annu; 1990 Apr; 25 Pt 1():171-210. PubMed ID: 2153277
    [Abstract] [Full Text] [Related]

  • 12. Flow cytometry in primary breast carcinomas: prognostic impact of S-phase fraction according to different analysis patterns.
    Michels JJ, Marnay J, Plancoulaine B, Chasle J.
    Cytometry B Clin Cytom; 2004 May; 59(1):32-9. PubMed ID: 15108168
    [Abstract] [Full Text] [Related]

  • 13. The flow-cytometric analysis of DNA content and S-phase fraction (SPF) of human breast cancer.
    Eskelinen M, Nordling S, Puittinen J, Pesonen E, Collan Y.
    Pathol Res Pract; 1989 Nov; 185(5):694-7. PubMed ID: 2626377
    [Abstract] [Full Text] [Related]

  • 14. Major salivary gland lesions: correlation of MR findings with flow cytometric DNA analysis and prognosis.
    Takashima S, Sone S, Horii A, Okamoto S, Yoshida J.
    AJR Am J Roentgenol; 1996 Nov; 167(5):1297-304. PubMed ID: 8911200
    [Abstract] [Full Text] [Related]

  • 15. Predictive value of flow cytometry for metastatic potential in breast cancer.
    Schmidt H, Wei JP, Yeh KA.
    Am Surg; 1999 May; 65(5):434-8. PubMed ID: 10231212
    [Abstract] [Full Text] [Related]

  • 16. DNA flow cytometry but not telomerase activity as predictor of disease-free survival in pT1-2/N0/G2 breast cancer.
    Pinto AE, André S, Pereira T, Silva G, Soares J.
    Pathobiology; 2006 May; 73(2):63-70. PubMed ID: 16943686
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.